Collegium Pharmaceutical: A Business Growing Into a Price That Has Already Left
The stock is down more than half from its 52-week high. The company just raised its...
Tilray Brands: A Dollar of Sales, Thirteen Cents of Losses, and a Stock Whose Valuation Multiple, If the Filed Revenue Trend Holds, Sits Near Its Decade Low
First, the shape of it Tilray's 10-K for fiscal year 2026 shows record revenue of $915...
Abbott Is Beating Its Targets. The Stock Is Down 23%. The Gap Is the Story.
Abbott Laboratories spent the better part of five years rebuilding its identity. The pandemic turned its...
Ionis Pharmaceuticals: Two FDA Approvals, Half the Stock Price
Two drugs won FDA approval in the span of three months. The stock lost nearly half...
The Margin the Market Has Decided to Ignore
Prestige Consumer Healthcare has spent two decades doing something quietly difficult: buying unglamorous drugstore brands, Clear...
AbbVie at $257: The Price That Needs Everything to Go Right
Humira once generated more annual revenue than the entire GDP of a small country. Then, in...
Indivior: Earnings Have Turned Positive. The Multiple Has Not Yet Moved in Step.
The story, briefly For most of its life as a public company, Indivior earned almost nothing,...
Amgen: The Stock Is Priced for a Future the Filings Haven’t Promised Yet
For most of the past decade, Amgen was a reliable but slow-moving machine: a biotech giant...
A 95% Gross Margin and a P/S Below Its Own Median: PTC Therapeutics’ Profitability Flip Is Real, and the Valuation Gap Raises Questions
In one breath PTC Therapeutics spent the better part of a decade burning cash on a...
Moderna at 28 Times Sales: One Trial Result Is Doing a Lot of Work
Before anything else Moderna's filed revenue has fallen every year since 2022, and the company is...
BullScope is an evidence-first investment research publication. Every note starts in the filings: what companies actually report, what the market assumes, and where the two disagree. We read the numbers so you can read the story. Not investment advice.